サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1726283

レジオネラ菌検査の世界市場：市場規模・シェア・動向分析 (種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

Legionella Testing Market Size, Share, & Trends Analysis Report By Type (Water Testing, IVD Testing), By End Use (Microbial Culture, Direct Fluorescent Antibody (DFA) Stain, PCR, Others), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
レジオネラ菌検査の世界市場：市場規模・シェア・動向分析 (種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年04月15日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レジオネラ菌検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のレジオネラ菌検査の市場規模は2030年までに5億4,740万米ドルに達すると予測され、2025年から2030年までのCAGRは8.2%になると予測されています。

ポンティアック熱や肺炎などのレジオネラ疾患の発生率の増加は、市場成長の主な要因の1つです。世界保健機関（WHO）によると、欧州、オーストラリア、米国では毎年、人口100万人当たり10～15件の新たな感染者が確認されています。

タイムリーなレジオネラ菌検査への志向の高まりは、迅速な回復や患者の予後の改善といった利点に起因しています。さらに、レジオネラ菌検査法をPCRやポイントオブケア検査などの先進診断技術と統合することで、予測期間中にこの市場の成長を促進することが期待されます。

レジオネラ菌検査プログラム、啓発キャンペーン、水質安全規制などの政府主導の取り組みにより、レジオネラ症例の検出と管理が世界的に増加すると推定されます。例えば、欧州では、厳格な規制により、水システムでの定期的なレジオネラ菌検査が義務付けられており、これが高度なレジオネラ菌検査法の需要を押し上げると予測されています。

レジオネラ菌検査市場：分析概要

  • 欧州は、レジオネラ症に関する意識の高まり、洗練された医療システム、公衆衛生保護イニシアティブ、英国やドイツなどの国々における検査義務化規制などの要因により、2024年には39.0%以上のシェアで世界のレジオネラ菌検査市場を独占しました。
  • IVD検査分野は、予測期間中、著しいCAGRで成長する見込みです。
  • 最終用途別では、PCR分野が2024年の売上高シェア37.7％で市場を独占しています。PCRは、その高い感度と迅速な処理時間により、細菌の正確かつ迅速な検出を可能にします。
  • 人口動態、環境要因などの要因によって、多くの地域で記録されるレジオネラ菌のアウトブレイクが増加し、需要を牽引すると予想されます。
  • 医療システムの大幅な強化、タイムリーな介入に関する意識の高まり、公衆衛生に関連する政府のイニシアチブは、予測期間中にこの業界に有利な成長機会を追加すると思われます。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 レジオネラ菌検査市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • レジオネラ菌検査市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 レジオネラ菌検査：種類別の推定・動向分析

  • 種類別ダッシュボード
  • レジオネラ菌検査市場：変動分析、種類別
  • 世界のレジオネラ菌検査：市場規模と動向分析、種類別（2018～2030年）
  • 水質検査
    • 市場推計・予測（2018～2030年）
  • 体外 (IVD) 診断検査
    • 市場推計・予測（2018～2030年）

第5章 レジオネラ菌検査市場：最終用途別の推定・動向分析

  • 用途別ダッシュボード
  • レジオネラ菌検査市場：変動分析、最終用途別
  • 世界のレジオネラ菌検査：市場規模と動向分析、最終用途別（2018～2030年）
  • 微生物培養
  • 直接蛍光抗体（DFA）染色
  • PCR
  • その他

第6章 レジオネラ菌検査市場：地域別の推定・動向分析

  • 地域別ダッシュボード
  • 市場シェア分析：地域別（2024年・2030年）
  • レジオネラ菌検査市場：主なポイント、地域別
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業のヒートマップ分析（2024年）
  • 企業プロファイル
    • Abbott
    • Beckman Coulter, Inc
    • BD
    • Bio-Rad Laboratories, Inc.
    • BIOMERIEUX
    • Eiken Chemical Co., Ltd.
    • Hologic, Inc.
    • Pro Lab Diagnostics Inc.
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Global legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 3. Global legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 4. Global legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 5. North America legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 7. North America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8. U.S. legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 9. U.S. legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Mexico legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 13. Mexico legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Europe legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 16. Europe legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Germany legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 18. Germany legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19. UK legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 20. UK legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 21. France legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 22. France legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Italy legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 24. Italy legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Spain legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 26. Spain legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Denmark legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 28. Denmark legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Sweden legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 30. Sweden legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Norway legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 32. Norway legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 36. China legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 37. China legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Japan legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 39. Japan legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40. India legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 41. India legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 42. South Korea legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 43. South Korea legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Australia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 45. Australia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Thailand legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 47. Thailand legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Latin America legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 50. Latin America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Brazil legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 52. Brazil legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Argentina legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 54. Argentina legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55. MEA legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 56. MEA legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 57. MEA legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 58. South Africa legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 59. South Africa legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62. UAE legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 63. UAE legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 65. Kuwait legionella testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Legionella testing market: market outlook
  • Fig. 10 Legionella testing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Legionella testing market driver impact
  • Fig. 16 Legionella testing market restraint impact
  • Fig. 17 Legionella testing market strategic initiatives analysis
  • Fig. 18 Legionella testing market: type movement analysis
  • Fig. 19 Legionella testing market: type outlook and key takeaways
  • Fig. 20 Water testing market estimates and forecast, 2018 - 2030
  • Fig. 21 IVD testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Legionella testing market: End use movement analysis
  • Fig. 23 Legionella testing market: End use outlook and key takeaways
  • Fig. 24 Microbial culture market estimates and forecasts, 2018 - 2030
  • Fig. 25 Direct Fluorescent Antibody (DFA) Stain market estimates and forecasts,2018 - 2030
  • Fig. 26 PCR market estimates and forecasts,2018 - 2030
  • Fig. 27 Others market estimates and forecasts,2018 - 2030
  • Fig. 28 Global Legionella testing market: Regional movement analysis
  • Fig. 29 Global Legionella testing market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 US market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 46 India market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-372-0

Legionella Testing Market Growth & Trends:

The global legionella testing market size is anticipated to reach USD 547.4 million by 2030 and is expected to experience a CAGR of 8.2% from 2025 to 2030, according to a new report by Grand View Research, Inc., the increasing incidence of legionella diseases, such as Pontiac fever and pneumonia, is one of the major factors contributing to the market's growth. According to the World Health Organization (WHO), nearly 10 to 15 new cases per million population are identified every year in Europe, Australia, and the U.S.

The growing inclination towards timely legionella testing can be attributed to advantages such as speedy recovery and improved patient outcome. Additionally, integrating legionella testing methods with advanced diagnostic technologies such as PCR and point-of-care testing are expected to fuel growth of this market in the forecast period.

Government-sponsored initiatives, including legionella testing programs, awareness campaigns, and water safety regulations, are estimated to increase the detection and management of legionella cases globally. For instance, in Europe, stringent regulations mandate regular Legionella testing in water systems, which is expected to boost the demand for advanced Legionella testing methods.

Legionella Testing Market Report Highlights:

  • Europe dominated the global legionella testing market with over 39.0% share in 2024 owing to factors such as increasing awareness regarding legionellosis, sophisticated healthcare systems, public health protection initiatives, and mandatory testing regulations in countries such as the UK and Germany.
  • The IVD testing segment is expected to grow at a significant CAGR over the forecast period.
  • Based on end use, the PCR segment dominated market with revenue share of 37.7% in 2024. PCR enables the precise and rapid detection of bacteria through its high sensitivity and quick turnaround time.
  • Increasing legionella outbreaks recorded in numerous regions driven by factors such as demography, environmental factors and others are expected to drive demand.
  • Significantly enhanced healthcare systems, growing awareness regarding timely interventions, and government initiatives associated with public health are likely to add lucrative growth opportunities to this industry over forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional out
  • 2.3. Competitive Insights

Chapter 3. Legionella Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Legionella Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Legionella Testing: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Legionella Testing Market: Type Movement Analysis
  • 4.3. Global Legionella Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Water Testing
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. IVD Testing
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Legionella Testing Market: End Use Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Legionella Testing Market: Application Movement Analysis
  • 5.3. Global Legionella Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Microbial culture
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Direct Fluorescent Antibody (DFA) Stain
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. PCR
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Legionella Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Segment Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Legionella Testing market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. U.K.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.K. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.2.5. Key country dynamics
      • 6.5.2.6. Regulatory framework/ reimbursement structure
      • 6.5.2.7. Competitive scenario
      • 6.5.2.8. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Aregentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 1.1.2. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Beckman Coulter, Inc
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. BD
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Bio-Rad Laboratories, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. BIOMERIEUX
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Eiken Chemical Co., Ltd.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Hologic, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Pro Lab Diagnostics Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Takara Bio Inc.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Thermo Fisher Scientific Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives